Delayed pharyngocutaneous fistula caused by molecular targeted therapy: a case report

Mioko Matsuo,Kazuki Hashimoto,Rina Jiromaru,Takashi Nakagawa
DOI: https://doi.org/10.1186/s13256-022-03621-2
2022-10-23
Journal of Medical Case Reports
Abstract:Molecular-targeted agents used as a treatment for cancer can cause some rare and serious adverse events such as, delayed wound healing. Depending on the anticancer drug used, temporary withdrawal may be recommended before and after surgery to avoid complications. Once a surgical incision has healed and closed completely, wounds rarely open because of the initiation of molecular targeted therapy several months to years after surgery. Here, we aimed to describe a rare complication of pharyngocutaneous fistula in two patients that was thought to be caused by molecular targeted therapy.
What problem does this paper attempt to address?